July 1, 2024CME Post-Test, Improving Outcomes for Patients With Schizophrenia, CHPR, July/August/September 2024 By successfully completing the test you will be awarded a certificate for 2 CME credit.
July 1, 2024Learning Objectives, Improving Outcomes for Patients with Schizophrenia, CHPR, July/August/September 2024 After reading these articles, you should be able to...
July 1, 2024By Sébastien Hardy, PharmD, BCPSAerobic Exercise Boosts Cognitive Training Benefits in Early SchizophreniaIncorporating a simple and low-cost intervention—aerobic exercise—into cognitive rehabilitation programs for patients with schizophrenia accelerates cognitive gains and improves school and work functioning.
July 1, 2024By Sébastien Hardy, PharmD, BCPSAntipsychotic Polypharmacy: Maybe Not So Risky After All?
July 1, 2024By J. Brandon Birath, PhDEstablishing a Token Economy in a Psychiatric Unit: Guidelines and Benefits
July 1, 2024By Shayan Rab, MDStreet Psychiatry: Providing Outreach and Care to the Unhoused Mentally Ill
December 8, 2023By Robert C. Meisner, MDKetamine and the Evolving Psychopharmacologic Pipeline for Depression
General PsychiatryWhat You Need to Know About Gepirone (Exxua) | Benefits, Side Effects, and Review of TrialsRead More
General PsychiatryPTSD 101: Nine Off-Label MedsA new medication is knocking on the door for FDA approval in PTSD, and it isn’t MDMA. We cover that, and 8 other off label medications.Listen now
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
-_-Benefits-Side-Effects-and-Review-of-Trials_Thumb.jpg?1727890706 "What You Need to Know About Gepirone (Exxua) _ Benefits, Side Effects, and Review of Trials_Thumb.jpg")
